Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000662925 | SCV000785873 | benign | Colorectal cancer, susceptibility to, 12 | 2017-12-21 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001701149 | SCV002568045 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499141 | SCV002805622 | likely benign | Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001356345 | SCV001551489 | uncertain significance | Carcinoma of colon | no assertion criteria provided | clinical testing | The POLE c.2865-5_2865-4delTT variant was not identified in the literature nor was it identified in the ClinVar or MutDB databases. The variant was identified in dbSNP (ID: rs767764560) as "NA", and the Cosmic database (1x, confirmed somatic, in melanoma of the eye). The variant was not identified in the control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.2865-5_2865-4delTT variant is located in the 3' splice region but does not affect the invariant -1 and -2 positions. However, positions -3 and -5 to -12 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. In silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Genome Diagnostics Laboratory, |
RCV001579561 | SCV001807692 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001701149 | SCV001917919 | benign | not specified | no assertion criteria provided | clinical testing |